BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2972054)

  • 1. Evaluation of the systemic anticholinergic activity of nasally administered ipratropium bromide.
    Laurikainen E; Koulu M; Kaila T; Scheinin M; Isalo E
    Rhinology; 1988 Jun; 26(2):133-8. PubMed ID: 2972054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasomotor rhinitis and the systemic absorption of ipratropium bromide.
    Kaila T; Suonpää J; Grénman R; Iisalo E
    Rhinology; 1990 Jun; 28(2):83-9. PubMed ID: 2143593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of oxitropium bromide and ipratropium bromide in asthma.
    Peel ET; Anderson G; Cheong B; Broderick N
    Eur J Respir Dis; 1984 Feb; 65(2):106-8. PubMed ID: 6230249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of ipratropium bromide and salbutamol on autonomic heart rate control.
    Kaya D; Barutcu I; Esen AM; Onrat E; Orman A; Unlu M
    Europace; 2004 Nov; 6(6):602-7. PubMed ID: 15519264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ipratropium bromide on nasal mucociliary transport.
    Ohi M; Sakakura Y; Murai S; Miyoshi Y
    Rhinology; 1984 Dec; 22(4):241-6. PubMed ID: 6240764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology and toxicology of Atrovent.
    Engelhardt A
    Scand J Respir Dis Suppl; 1979; 103():110-5. PubMed ID: 155286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticholinergic drugs in airways obstruction.
    Anderson G
    Postgrad Med J; 1983; 59 Suppl 3():64-5. PubMed ID: 6227880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose effects of inhaled ipratropium bromide on the impedance of the respiratory system in normal subjects.
    Wesseling GJ; Vonk JM; Greve LH; Wouters EF
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):33-8. PubMed ID: 2137435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical pharmacological trials of a new metered dose inhaler, IK-6, a combination of the bronchodilators fenoterol and ipratropium bromide (author's transl)].
    Kaik G; Kaik B; Laggner A
    Wien Med Wochenschr; 1980 Jun; 130(11):385-93. PubMed ID: 6449783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic effects in antagonism of neuromuscular blockage: atropine-pyridostigmine versus ipratropium bromide-pyridostigmine].
    Stoyanov M; Müller H; Lobisch M; Hempelmann G
    Anaesthesist; 1984 Oct; 33(10):499-503. PubMed ID: 6239562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effect of ipratropium bromide aerosol against bronchospasm induced by hyperventilation and the inhalation of allergen, methacholine and histamine.
    Clarke PS; Jarrett RG; Hall GJ
    Ann Allergy; 1982 Mar; 48(3):180-3. PubMed ID: 6461281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal ipratropium: literature abstracts and comments.
    Mygind N; Borum P
    Rhinol Suppl; 1989; 9():37-44. PubMed ID: 2534054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the bronchodilatory action and side-effects of ipratropium bromide and thiazinamium methyl sulphate: a long-term, double-blind, crossover trial in patients with chronic bronchitis.
    Verheijen-Breemhaar L; Bogaard JM; Hilvering C
    Pharmatherapeutica; 1982; 3(3):180-7. PubMed ID: 6127719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ipratropium bromide after single dose inhalation and oral and intravenous administration.
    Ensing K; de Zeeuw RA; Nossent GD; Koëter GH; Cornelissen PJ
    Eur J Clin Pharmacol; 1989; 36(2):189-94. PubMed ID: 2524387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyl atropine bromide versus atropine sulphate. A clinical comparison.
    Rupreht J; Stienstra R; Dworacek B; Eggels PJ
    Acta Anaesthesiol Belg; 1983 Dec; 34(4):301-7. PubMed ID: 6369862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal disorders and anticholinergic therapy.
    Borum P
    Postgrad Med J; 1987; 63 Suppl 1():61-8. PubMed ID: 2962076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ipratropium bromide in obstructive lung disease.
    Mann KV; Leon AL; Tietze KJ
    Clin Pharm; 1988 Sep; 7(9):670-80. PubMed ID: 2977109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemodynamic effects of ipratropium bromide in comparison with atrial stimulation].
    Bergbauer M; Nebel W; Schneider M; Sabin G
    Arzneimittelforschung; 1983; 33(7):977-9. PubMed ID: 6226295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of freon inhalation on maximal expiratoryflows and heart rhythm after treatment with salbutamol and ipratropium bromide.
    Thiessen B; Pedersen OF
    Eur J Respir Dis; 1980 Jun; 61(3):156-61. PubMed ID: 6449369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Product characteristics and pharmacokinetics of intranasal ipratropium bromide.
    Wood CC; Fireman P; Grossman J; Wecker M; MacGregor T
    J Allergy Clin Immunol; 1995 May; 95(5 Pt 2):1111-6. PubMed ID: 7751527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.